Luxembourg vs Norway: Cause of death, by non-communicable diseases, ages 15-59
Luxembourg
74.8%
in 2021
Norway
75.6%
in 2021
Luxembourg rank
25th
Norway rank
22nd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Luxembourg
- Norway
How they compare
Norway currently reports 75.6% against 74.8% in Luxembourg, a difference of 0.8%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Norway ahead.
Luxembourg ranks 25th and Norway ranks 22nd of 185 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Luxembourg | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.2% | 78.8% | 5.5% | Norway |
| 2010s | 77.3% | 78.7% | 1.4% | Norway |
| 2020s | 75.3% | 76.6% | 1.3% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Luxembourg or Norway?
- Norway, at 75.6% against 74.8% in Luxembourg as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Luxembourg and Norway?
- 0.8%, with Norway ahead.
- How many years of comparable data are there for Luxembourg and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Luxembourg and Norway rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Luxembourg ranks 25th and Norway ranks 22nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.